Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: A review

Therapeutic Apheresis

Volumn 5, Issue 3, 2001, Pages 182-185

  Bosch, Thomas ^a   Wendler, Thorsten ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Hemolytic uremic syndrome; Metalloprotease; Plasmapheresis; Thrombotic thrombocytopenic purpura; Von Willebrand factor

Indexed keywords

COMPLEMENT FACTOR H; FRESH FROZEN PLASMA; METALLOPROTEINASE; MITOMYCIN C; POLYMER; VON WILLEBRAND FACTOR;

BONE MARROW TRANSPLANTATION; COMPLEMENT ACTIVATION; DIARRHEA; FAMILIAL DISEASE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MICROVASCULATURE; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOGENESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION;

EXTRACORPOREAL CIRCULATION; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; PLASMAPHERESIS; PREGNANCY; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 0034945768     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2001.00342.x     Document Type: Review

References (21)

1. Pathogenesis and treatment of thrombotic microangiopathy
2. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura - New insights into underlying biochemical mechanisms
3. The hemolytic uremic syndrome
4. Hemolytic uremic syndrome
5. Factor VIII and von Willebrand factor
6. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation
7. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma
8. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
9. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
10. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
11. Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome
12. Familial hemolytic uremic syndrome and homozygous factor H deficiency
13. Genetic studies into inherited and sporadic hemolytic uremic syndrome
14. Human complement factor H deficiency associated with hemolytic uremic syndrome
15. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome
16. Chronisch rezidivierende thrombotisch-thrombozytopenische Purpura (M. Moschcowitz)
17. Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura
18. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura
19. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
20. Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation
21. Total recovery of acute renal failure (ARF) after dialysed hemolytic uremic syndrome (HUS) treated with or without membrane plasma separation (MPS)